XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Class A and Class B common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member            
Shares outstanding, beginning of the period (in shares) at Dec. 31, 2018   409.6          
Shareholders equity, beginning balance at Dec. 31, 2018 $ 676.8 $ 0.0 $ 2,337.5 $ (1,659.5) $ (1.2) $ 1.0 $ 1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Release of restricted stock units (in shares)   5.5          
Shares repurchased for tax withholdings on release of restricted stock (in shares)   (2.0)          
Shares repurchased for tax withholdings on release of restricted stock (48.1)   (35.6) (12.5)      
Exercise of stock options and awards (in shares)   0.3          
Exercise of stock options and awards 2.0   2.0        
Assumed stock options in connection with acquisition 0.8   0.8        
Stock-based compensation 123.7   123.7        
Other comprehensive income 3.1       3.1    
Net income (loss) (29.1)     (29.1)      
Shares outstanding, end of the period (in shares) at Jun. 30, 2019   413.4          
Shareholders equity, ending balance at Jun. 30, 2019 730.2 $ 0.0 2,428.4 (1,700.1) 1.9    
Shares outstanding, beginning of the period (in shares) at Mar. 31, 2019   411.4          
Shareholders equity, beginning balance at Mar. 31, 2019 704.9 $ 0.0 2,377.8 (1,674.7) 1.8    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Release of restricted stock units (in shares)   2.9          
Shares repurchased for tax withholdings on release of restricted stock (in shares)   (1.0)          
Shares repurchased for tax withholdings on release of restricted stock (22.6)   (18.6) (4.0)      
Exercise of stock options and awards (in shares)   0.1          
Exercise of stock options and awards 1.1   1.1        
Stock-based compensation 68.1   68.1        
Other comprehensive income 0.1       0.1    
Net income (loss) (21.4)     (21.4)      
Shares outstanding, end of the period (in shares) at Jun. 30, 2019   413.4          
Shareholders equity, ending balance at Jun. 30, 2019 730.2 $ 0.0 2,428.4 (1,700.1) 1.9    
Shares outstanding, beginning of the period (in shares) at Dec. 31, 2019   417.0          
Shareholders equity, beginning balance at Dec. 31, 2019 $ 808.4 $ 0.0 2,531.3 (1,726.2) 3.3    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Release of restricted stock units (in shares)   6.1          
Shares repurchased for tax withholdings on release of restricted stock (in shares) (2.2) (2.2)          
Shares repurchased for tax withholdings on release of restricted stock $ (44.0)   (20.3) (23.7)      
Repurchases of common stock (in shares)   (7.4)          
Repurchases of common stock $ (139.8)   (68.5) (71.3)      
Exercise of stock options and awards (in shares) 0.3 0.3          
Exercise of stock options and awards $ 1.5   1.5        
Stock-based compensation 116.4   116.4        
Other comprehensive income 4.1       4.1    
Net income (loss) 56.8     56.8      
Shares outstanding, end of the period (in shares) at Jun. 30, 2020   413.8          
Shareholders equity, ending balance at Jun. 30, 2020 803.4 $ 0.0 2,560.4 (1,764.4) 7.4    
Shares outstanding, beginning of the period (in shares) at Mar. 31, 2020   415.1          
Shareholders equity, beginning balance at Mar. 31, 2020 800.4 $ 0.0 2,528.5 (1,726.6) (1.5)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Release of restricted stock units (in shares)   3.4          
Shares repurchased for tax withholdings on release of restricted stock (in shares)   (1.2)          
Shares repurchased for tax withholdings on release of restricted stock (25.1)   (11.0) (14.1)      
Repurchases of common stock (in shares)   (3.7)          
Repurchases of common stock (75.8)   (34.6) (41.2)      
Exercise of stock options and awards (in shares)   0.2          
Exercise of stock options and awards 0.9   0.9        
Stock-based compensation 76.6   76.6        
Other comprehensive income 8.9       8.9    
Net income (loss) 17.5     17.5      
Shares outstanding, end of the period (in shares) at Jun. 30, 2020   413.8          
Shareholders equity, ending balance at Jun. 30, 2020 $ 803.4 $ 0.0 $ 2,560.4 $ (1,764.4) $ 7.4